SlideShare a Scribd company logo
PRESENTED BY:
ACHAL YAWALKAR
M.PHARM I YEAR
PHARMACEUTICAL CHEMISTRY
GUIDED BY:
Dr. B.R. PRASHANTHA KUMAR
ASSOCIATE PROFESSOR
DEPT OF PHARMACEUTICAL CHEMISTRY
Elements
1. WHAT ARE ISOMERS ?
2. WHAT ARE STEREOISOMERS ?
3. WHAT IS CHIRALITY ?
4. WHAT DO YOU UNDERSTAND BY
THE TERM ENATIOSELECTIVITY &
HOW IS IT RELATED TO VARIOUS
PHARMACOKINETIC PARAMETERS
?
STEREOCHEMISTRY
Stereochemistry is the branch of chemistry that involves “the study of the different spatial arrangements of
atoms in molecules”.
 Stereochemistry is the ‘chemistry of space’ , that is
stereochemistry deals with the spatial arrangements of atoms
and groups in a molecule.
 Stereochemistry can trace its roots to the year 1842 when
the French chemist Louis Pasteur made an observation that
the salts of tartaric acid collected from a wine production vessel
have the ability to rotate plane-polarized light, whereas the
same salts from different sources did not have this ability.
ISOMERS:
Stereoisomers are molecules having the
same molecular formula and the atomic
arrangement, but differ in their spatial
arrangement.
Isomers are compounds that contain exactly the
same number of atoms, i.e., they have exactly
the same empirical formula, but differ from each
other by the way in which the atoms are
arranged.
STEREOISOMERS:
Constitutional isomers, also known as
structural isomers, are specific types of
isomers that share the same molecular
formula but have different bonding atomic
organization and bonding patterns.
CONSTITUTIONAL
ISOMERS:
GEOMETRIC ISOMERS:
Geometric isomers are two or more coordination compounds which contain
the same number and types of atoms, and bonds (i.e., the connectivity
between atoms is the same), but which have different spatial arrangements
of the atoms.
 There are 2 types of geometric isomers, ‘cis’ and ‘trans’.
-cis isomers: when similar groups are present on the same side of the
double bonds, then they are termed as cis.
- trans isomers: when similar groups are present on the opposite sides
of the double bonds then they are called trans isomers.
 cis-diethylstilbestrol has only 7% of the estrogenic activity of trans-
diethylstilbesterol.
 Cisplatin have anticancer activity where ae trans platin is an inactive
compound.
 In chemistry, a molecule or ion is called chiral if it cannot be superposed on its mirror image by any
combination of rotations, translations, and some conformational changes.
 Chirality is the property of being non identical to ones mirror image.
CHIRALITY:
 Chiral center is defined as the atom bearing 4 different atoms or group of atoms.
 Molecules that form nonsuperimposable mirror images, and thus exist
as enantiomers, are said to be chiral molecules.
 For a molecule to be chiral, it cannot contain a plane of symmetry.
A plane of symmetry is a plane that bisects an
object (a molecule, in this case) in such a way
that the two halves are identical mirror images.
ENATIOSELECTIVITY:
The term enantioselectivity refers to the efficiency with which the reaction produces one
enantiomer.
ENANTIOMERS DIASTEREOMERS
 Enantiomers are stereoisomers
that are non-superimposable
mirror images.
 Have identical properties.
 Similar shapes
 Diastereomers are stereoisomers that
are non superimposable and are not
mirror images.
 Have distinct physical properties.
 Have different molecular shapes.
ENANTIOMERS
 Enantiomers consist of a pair of molecules that are mirror images of each
other and are not superimposable.
 When a molecule contains only one chiral centre , the two stereoisomers are
known as enantiomers.
 These may be referred to or labelled using the configurational descriptors as
either:
 R(rectus meaning right handed) or S(sinister meaning left handed),
 D(dextrorotatory)or L (laevorotatory)
 E-Entgegen (high priority groups on opposite side of double bond) or Z-
Zusamen (high priority groups on
same side of double bond)
The most famous example of a chiral drug is Thalidomide.
Thalidomide has a tragic history :
 It was introduced in Germany in 1957 as a sedative and hypnotic and was marketed over the
counter largely as a drug for treating morning sickness in pregnant women.
 In the following few years, about 10,000 infants worldwide were born with phocomelia, or limb
malformation. Only half of the infants survived, and some of those who did had other defects in
addition to limb deficiencies.
 Thalidomide exists in two mirror-image forms: it is a racemic mixture of (R)- and (S)-enantiomers. The (R)-
enantiomer, shown in the figure, has sedative effects, whereas the (S)-isomer is teratogenic. Under
biological conditions, the isomers interconvert, so separating the isomers before use is ineffective.
The thalidomide disaster caused many
countries to tighten drug approval regulations.
 Vigabatrin, one of the most widely used
antiepileptic drugs, is marketed and administered
as a racemic mixture in which only S-enantiomer is
therapeutically effective.
R- Vigabatrin
S-Vigabatrin
 Tramadol is marketed as a racemic mixture of both R- and S-
stereoisomers, because the two isomers complement each other's
analgesic activities .
 The (+)-isomer is predominantly active as an opiate with a higher
affinity for the µ-opiate receptor (20 times higher affinity than the (-)-
isomer).
PHARMACOKINETIC PARAMETERS:
1.Absorption
Passive intestinal absorption
Carrier transporter stereoselectivity
Oral bioavailability
Local blood flow
2. Distribution
Protein binding
Tissue distribution
Storage mechanism
Tissue uptake transporter
Efflux process
3.Metabolism
First pass metabolism
Phase 1 and Phase 2 metabolism
4. Elimination
Glomerular Filtration
Active secretion
Passive & active reabsorption.
The process of movement of drug from its site of administration to systemic circulation is
called as absorption.
Most important mechanism of drug absorption is passive diffusion through biological
membranes, a process that is dependent upon the physicochemical properties of the
molecule:
i. Lipid solubility
ii. pKa
iii. Molecular size
iv. Dissloution time
v. Drug stability …..etc
If a chiral drug is absorbed by a passive process then differences between enantiomers
would not be expected.
In contrast , diastereoisomers may show differences in absorption as a result of the
differences in their solubility i.e
Enantiomeric
Do not show any differences in the absorption rate
Diastereomeric
May show differences in absorption as a result of the
differences in their solubility.
The aqueous solubility of ampicillin with 2R stereochemistry in
the acylated side chain (corresponding to D- configuration) is
greater than that of 2S epimer (L-configuration in side chain).
Many of the b-lactam antibiotics are substrates for the gut dipeptide
transport system and as such their absorption would be expected to be
stereoselective.
 The influence of the stereochemistry of the 7-acyl side chain on the
absorption of the diastereoisomers of cefalexin has been
investigated in the rat.
 Both diastereoisomers are substrates for the carrier-mediated
transport system with the L-epimer showing a higher affinity than,
and acting as a competitive inhibitor for, D-cefalexin transport.
 However, the L-epimer is also more susceptible to the intestinal
wall peptidases and cannot be detected in serum, whereas the D-
isomer is well absorbed. The drug is marketed as the single D-
epimer
i)There was 15% difference in bioavailability of
the enantiomers of Atenolol. It was postulated
that this was a result of an enantioselective
active absorption.
ii)Esomeprazole( Nexium) is more bioavailable than racemic omeprazole( Prilosec).
iii)Greater bioavailability of (-)R-terbutaline compared
to the less active (+)S- enantiomer is due to the result
of
stereoselectivity in first pass metabolism and due to (-
) enantiomer posses increasing membrane
permeability in absorption.
Difference in the absorption of enantiomers may also due to
difference in their effect on local blood flow.
(-) Bupivacaine has a longer duration of action than (+) Bupivacaine
following intradermal
injection. This difference in activity is due to vasoconstrictor effects
of the (-) enantiomer reducing
blood flow locally.
The majority of the drugs undergo reversible binding to plasma
proteins.
• In case of chiral drugs, the drug enantiomer- protein complexes
are diastereoisomeric
and individual enantiomers would be expected to exhibit
differences in binding affinity
to the circulating proteins.
• The differences in the binding affinity result in differences between
enantiomers in free
or unbound fraction that is able to distribute into the tissue.
The two most important plasma proteins with respect to drug binding are human
serum albumin (HSA) and alpha1-acid glycoprotein (AGP).
a) Generally acidic drugs bind to HSA and basic drugs bind to AGP.
b) Differences between enantiomers in the plasma protein binding may be relatively
small and in some cases less than1%.
Stereoselectivity in plasma protein binding also influences clearance for drugs, total
clearance being proportional to fraction bound.
Differences between enantiomers for plasma protein-binding sites may also result in
pharmacokinetic complications.
Most of the drug undergo reversible binding to plasma proteins.
Types of plasma proteins are-
-Human serum albumin -Weak acid to weak base drugs
-Alpha-1 acid glycoproteins-Basic drugs
-Lipoproteins- Basic lipophilic drugs
-Alpha-1 globulin-Steroids
-Alpha-2 globulin-Vitamins
-Hemoglobin -Phenytoin, pentobarbital, etc
Enantiomers display different magnitudes of stereoselectivity between various proteins found in
plasma.
1. R- Propranolol binding to albumin is greater than S- propranolol and S enantiomer binding to
alpha 1 glycoprotein is greater than R- albumin.
2. S- warfarin extensively binds to albumin than R – warfarin thus posses lower volume of
distribution.
3.Levo cetrizin has lesser volume of distribution than its dextro isomer.
R-Propranolol S- Warfarin Levo -cetrizin
Enantioselectivity in binding may also vary between HSA and AGP.
R- Propranolol
Highly albumin bound
Less potent
Highly metabolized
Low plasma concentration
S- Propranolol
Highly bound to AGP available as unbound
40 to 100 time more potent
Less metabolized
High plasma concentration
(S)-oxazepam hemi succinate binds to HSA with an affinity 40
times than that of R-enantiomer.
Enantioselective protein binding interaction was
reported between warfarin and lorazepam acetate.
 Where, R, S- warfarin allosterically increased the
binding of S – Lorazepam acetate, but there was no
effect of them on R enantiomer.
 Similarly, S- lorazepam acetate increased the
binding of R,S – Warfarin.
Storage mechanisms: The S
enantiomer of adreno receptor
antagonists propranolol and atenolol
undergo selective storage and
secretion.
The uptake of (-)- atenolol in to the
storage granules has been reported to
be 5 fold that of (+)- enantiomer.
Stereoselective distribution may also occur as a result of
interactions with: Tissue uptake transporter:
E.g.: the BBB clearance of the R-enantiomer is four fold
greater than that of
either (S)-or racemic baclofen (Muscle relaxant).
Stereoselectivity in metabolism may be associated with the
binding of the substrate to the enzyme, and therefore associated
with the chirality of the enzyme-binding site.
Alternatively, selectivity may be associated with catalysis due to
differential reactivity and/or orientation of potential target groups
with respect to the enzyme catalytic site.
The individual enantiomers of a racemic drug may be
metabolized by different routes to yield different products and
they are metabolized at different rates.
The stereoselectivity of the reactions of drug
metabolism may be associated with:
• 1. Substrate stereoselectivity, i.e. the selective
metabolism of one enantiomer compared to the
other in either rate and/or route of metabolism
• 2. Product stereoselectivity, i.e. the preferential
formation of a particular stereoisomer rather than
other possible stereoisomers
• 3. Substrate product specificity, i.e. the selective
metabolism of one enantiomer resulting in the
preferential formation of one of a number of possible
diastereoisomeric products.
Prochiral to chiral
transformations
Chiral to chiral
transformations
Chiral to
diastereo
isomer
transformations
Chiral to achiral
transformations
Chiral
inversions
PROCHIRAL TO CHIRAL TRANSFORMATION:
The molecule acquires chirality by metabolism, which
may take place at either a prochiral centre or on an
enantiotopic group bonded to it.
Examples: The antiepileptic drug phenytoin has a
prochiral center at carbon -5 of the hydantoin ring
system and the two phenyl rings are enantiotopic as
indicated by pro-S and pro-R. The major route of
metabolism of phenytoin in both animals and humans
involves aromatic oxidation which in human shows
product stereoselectivity for formation of (S)-4-
hydroxyphenytoin.
CHIRAL TO CHIRAL TRANSFORMATION:
In this type of transformations metabolism take place at a site in the
molecule that does not alter the chirality of the metabolite relative to
that of the drug.
Example: Esmolol is an ultrashort acting relatively cardioselective B-
adrenoreceptor antagonist, is used as a racemate but the
pharmacological activity resides in the enantiomer of the S-
configuration; the R-enantiomer is pharmacologically inactive.
The ester functionality of esmolol is hydrolysed by the enzyme in
blood esterases . The hydrolysis of S-esmolol is faster than that of
the R-enantiomer in the animals whereas in human beings the
hydrolysis of both enantiomers occur at similar rates.
CHIRAL TO DIASTEREOISOMER
TRANSFORMATION:
This type of transformation involves the introduction of
an additional stereogenic centre into a chiral molecule .
Such centres may arise by a phase 1 or
functionalization, metabolic reaction at a prochiral
centre or by a phase 2, or conjugation, process by
reaction with a chiral conjugating agent.
Example: Reaction of a first type include reduction of
the prochiral ketone group in warfarin to yield a pair of
diastereoisomeric warfarin alcohols. In both rat and
human, the reduction is substrate selective for (R)-
warfarin and the predominantly formed isomer of the
alcohol has S-configuration at the new centre.
CHIRAL TO ACHIRAL
TRANSFORMATIONS:
In reactions of this type the biotransformation
results in a loss of chirality, the reaction taking place
at the stereogenic centre.
Example: 1,4-dihydropyridine calcium channel
blockers nitrendipine and nilvadipine .
CHIRAL INVERSION:
Chiral inversion is a relatively rare metabolic transformation
and involves the conversion of a stereoisomer to its
enantiomer with no other chemical change to the molecule.
Example: The reaction was initially observed in 2-arylpropionic
acid NSAID’s e.g. ibuprofen and since then it has been found to
occur with the chemically related 2-aryloxypropionates, which
are used as herbicides e.g. haloxyfop
Renal excretion is the net result of glomerular filteration, active secretion and passive &
active reabsorption.
Since glomerular filteration is a passive process differences between enantiomers
would not be expected.
However, apparent stereoselectivity in renal clearance may arise as a consequence of
stereoselectivity in protein binding.
Active renal tubular secretion is thought to be responsible for the
differential clearance of the enantiomers of number of basic drugs with
stereoselectivities in the range of 1.1 to 3.0
Eg : The renal clearance of quinidine is four
times greater than its diastereoisomer quinine.
For those agents that undergo active tubular secretions,
the interactions between the enantiomers may occur in
such a way that their excretions differs as single
enantiomer or as a racemates.
Ex- S- Ofloxacin administration with more of its R –
enantiomer resulted in reduction of renal clearance of S-
enantiomer. Mechanism followed was by competitive
inhibitor of active transport system
BIBLOGRAPHY:
a) Smith and William’s introduction to principles of drug
design, second edition, published by John wright,
Pg.no.140-149
b) Burger’s Medicinal Chemistry And Drug Discovery, 6th
edition, pg.no.782-787
c) Thomas L.L and David A Williams, Foye’s Principle of
Medicinal Chemistry, 6th edition, Wolters Kluwer, Chapter
2 pg.24-36
STEREOCHEMISTRY AND DRUG ACTION.pptx

More Related Content

What's hot

Combating drug resistance
Combating drug resistanceCombating drug resistance
Combating drug resistance
Ashok Jangra
 
Stereochemistry
StereochemistryStereochemistry
Stereochemistry
AZMIN MOGAL
 
Pinner pyrimidine synthesis
Pinner pyrimidine  synthesisPinner pyrimidine  synthesis
Pinner pyrimidine synthesis
JACOB THON BIOR
 
Strategies for Heterocycle ring synthesis
Strategies for Heterocycle ring synthesis Strategies for Heterocycle ring synthesis
Strategies for Heterocycle ring synthesis
SACHINKUMARVISHWAKAR4
 
Heterocyclic Organic Reaction - By Vishal Dakhale
Heterocyclic Organic Reaction - By Vishal DakhaleHeterocyclic Organic Reaction - By Vishal Dakhale
Heterocyclic Organic Reaction - By Vishal Dakhale
VishalDakhale
 
SYNTHETIC REAGENTS AND APPLICATION
SYNTHETIC REAGENTS AND APPLICATIONSYNTHETIC REAGENTS AND APPLICATION
SYNTHETIC REAGENTS AND APPLICATION
Binuja S.S
 
Traube purine synthesis
Traube purine synthesisTraube purine synthesis
Traube purine synthesis
Karanvir Rajput
 
Active constituent of drugs used in diabetic therapy
Active constituent of drugs used in diabetic therapyActive constituent of drugs used in diabetic therapy
Active constituent of drugs used in diabetic therapy
Akshay Kank
 
Biological drug targets.pptx
Biological drug targets.pptxBiological drug targets.pptx
Biological drug targets.pptx
PurushothamKN1
 
Analog design medicinal chemistry
Analog design medicinal chemistryAnalog design medicinal chemistry
Analog design medicinal chemistry
Mohit umare
 
Suzuki and Shapiro reaction
Suzuki and Shapiro reaction Suzuki and Shapiro reaction
Suzuki and Shapiro reaction
Shalinee Chandra
 
Peptidomimetics
PeptidomimeticsPeptidomimetics
Peptidomimetics
AkshayYadav176
 
Enzyme inhibition for M.Pharm
Enzyme inhibition for M.PharmEnzyme inhibition for M.Pharm
Enzyme inhibition for M.Pharm
Shikha Popali
 
Validation & Diversity of drug targets
Validation & Diversity of drug targetsValidation & Diversity of drug targets
Validation & Diversity of drug targets
SnigdhaBharadwaaj
 
Knorr Pyrazole Synthesis (M. Pharm)
Knorr Pyrazole Synthesis (M. Pharm) Knorr Pyrazole Synthesis (M. Pharm)
Knorr Pyrazole Synthesis (M. Pharm)
MohdShafeeque4
 
Natural products as leads for new pharmaceuticals
Natural products as leads  for new pharmaceuticalsNatural products as leads  for new pharmaceuticals
Natural products as leads for new pharmaceuticals
Shikha Popali
 
Wiliknsons reagent
Wiliknsons reagentWiliknsons reagent
Wiliknsons reagent
Shikha Popali
 
ANALOG DESIGN.pdf
ANALOG DESIGN.pdfANALOG DESIGN.pdf
ANALOG DESIGN.pdf
ShivalingMP
 
Protecting groups
Protecting groupsProtecting groups
Protecting groups
VIKAS MATHAD
 
Sythesis of heterocyclic drugs ketoconazole and metronidazole
Sythesis of heterocyclic drugs ketoconazole and metronidazoleSythesis of heterocyclic drugs ketoconazole and metronidazole
Sythesis of heterocyclic drugs ketoconazole and metronidazole
andhra university
 

What's hot (20)

Combating drug resistance
Combating drug resistanceCombating drug resistance
Combating drug resistance
 
Stereochemistry
StereochemistryStereochemistry
Stereochemistry
 
Pinner pyrimidine synthesis
Pinner pyrimidine  synthesisPinner pyrimidine  synthesis
Pinner pyrimidine synthesis
 
Strategies for Heterocycle ring synthesis
Strategies for Heterocycle ring synthesis Strategies for Heterocycle ring synthesis
Strategies for Heterocycle ring synthesis
 
Heterocyclic Organic Reaction - By Vishal Dakhale
Heterocyclic Organic Reaction - By Vishal DakhaleHeterocyclic Organic Reaction - By Vishal Dakhale
Heterocyclic Organic Reaction - By Vishal Dakhale
 
SYNTHETIC REAGENTS AND APPLICATION
SYNTHETIC REAGENTS AND APPLICATIONSYNTHETIC REAGENTS AND APPLICATION
SYNTHETIC REAGENTS AND APPLICATION
 
Traube purine synthesis
Traube purine synthesisTraube purine synthesis
Traube purine synthesis
 
Active constituent of drugs used in diabetic therapy
Active constituent of drugs used in diabetic therapyActive constituent of drugs used in diabetic therapy
Active constituent of drugs used in diabetic therapy
 
Biological drug targets.pptx
Biological drug targets.pptxBiological drug targets.pptx
Biological drug targets.pptx
 
Analog design medicinal chemistry
Analog design medicinal chemistryAnalog design medicinal chemistry
Analog design medicinal chemistry
 
Suzuki and Shapiro reaction
Suzuki and Shapiro reaction Suzuki and Shapiro reaction
Suzuki and Shapiro reaction
 
Peptidomimetics
PeptidomimeticsPeptidomimetics
Peptidomimetics
 
Enzyme inhibition for M.Pharm
Enzyme inhibition for M.PharmEnzyme inhibition for M.Pharm
Enzyme inhibition for M.Pharm
 
Validation & Diversity of drug targets
Validation & Diversity of drug targetsValidation & Diversity of drug targets
Validation & Diversity of drug targets
 
Knorr Pyrazole Synthesis (M. Pharm)
Knorr Pyrazole Synthesis (M. Pharm) Knorr Pyrazole Synthesis (M. Pharm)
Knorr Pyrazole Synthesis (M. Pharm)
 
Natural products as leads for new pharmaceuticals
Natural products as leads  for new pharmaceuticalsNatural products as leads  for new pharmaceuticals
Natural products as leads for new pharmaceuticals
 
Wiliknsons reagent
Wiliknsons reagentWiliknsons reagent
Wiliknsons reagent
 
ANALOG DESIGN.pdf
ANALOG DESIGN.pdfANALOG DESIGN.pdf
ANALOG DESIGN.pdf
 
Protecting groups
Protecting groupsProtecting groups
Protecting groups
 
Sythesis of heterocyclic drugs ketoconazole and metronidazole
Sythesis of heterocyclic drugs ketoconazole and metronidazoleSythesis of heterocyclic drugs ketoconazole and metronidazole
Sythesis of heterocyclic drugs ketoconazole and metronidazole
 

Similar to STEREOCHEMISTRY AND DRUG ACTION.pptx

Chiral drug
Chiral drugChiral drug
Chiral drug
Rudra madhab
 
STEREOCHEMISTRY.pptx
STEREOCHEMISTRY.pptxSTEREOCHEMISTRY.pptx
STEREOCHEMISTRY.pptx
PurushothamKN1
 
chiral pharmacokinetic
chiral pharmacokineticchiral pharmacokinetic
chiral pharmacokinetic
maryam kazemi
 
Chiral catalysts
Chiral catalystsChiral catalysts
Chiral catalysts
Roshen Reji Idiculla
 
Clinical pharmacokinetics and pharmacodynamics of stereo isomeric drugs
Clinical pharmacokinetics and pharmacodynamics of stereo isomeric drugsClinical pharmacokinetics and pharmacodynamics of stereo isomeric drugs
Clinical pharmacokinetics and pharmacodynamics of stereo isomeric drugs
Sazan Jamil Ali
 
Enzymes - A complete introduction and applications
Enzymes - A complete introduction and applicationsEnzymes - A complete introduction and applications
Enzymes - A complete introduction and applications
Indhra Yogaesh
 
Gene Cards Assignment
Gene Cards AssignmentGene Cards Assignment
Gene Cards Assignment
Gina Buck
 
Des.term paper
Des.term paperDes.term paper
Des.term paper
dessyofosu
 
Complexation & protein binding
Complexation & protein bindingComplexation & protein binding
Complexation & protein binding
JILSHA123
 
medicinal chemistry .pptx
medicinal chemistry .pptxmedicinal chemistry .pptx
medicinal chemistry .pptx
Justalazydudewithgla
 
Plasma Membrane (Structure and Functions)
 Plasma Membrane (Structure and Functions) Plasma Membrane (Structure and Functions)
Plasma Membrane (Structure and Functions)
Meerut College
 
Drug discovery 30
Drug discovery 30Drug discovery 30
Drug discovery 30
nitin lambe
 
Stereochemistry
StereochemistryStereochemistry
Stereochemistry
Muhammad Rashad
 
William Stockham Mchem Project
William Stockham Mchem ProjectWilliam Stockham Mchem Project
William Stockham Mchem ProjectBill Stockham
 
Structure activity relationship main
Structure activity relationship mainStructure activity relationship main
Structure activity relationship main
Sumit Kumar
 
Drug discovery 30
Drug discovery 30Drug discovery 30
Drug discovery 30
nitin lambe
 
Assignment on isomerism
Assignment on isomerismAssignment on isomerism
Assignment on isomerism
azamushahiullah prottoy
 
Hypotonic Isotonic And Hypertonic Solutions
Hypotonic Isotonic And Hypertonic SolutionsHypotonic Isotonic And Hypertonic Solutions
Hypotonic Isotonic And Hypertonic Solutions
Kimberly Jones
 

Similar to STEREOCHEMISTRY AND DRUG ACTION.pptx (20)

Chiral drug
Chiral drugChiral drug
Chiral drug
 
STEREOCHEMISTRY.pptx
STEREOCHEMISTRY.pptxSTEREOCHEMISTRY.pptx
STEREOCHEMISTRY.pptx
 
chiral pharmacokinetic
chiral pharmacokineticchiral pharmacokinetic
chiral pharmacokinetic
 
Chiral catalysts
Chiral catalystsChiral catalysts
Chiral catalysts
 
Clinical pharmacokinetics and pharmacodynamics of stereo isomeric drugs
Clinical pharmacokinetics and pharmacodynamics of stereo isomeric drugsClinical pharmacokinetics and pharmacodynamics of stereo isomeric drugs
Clinical pharmacokinetics and pharmacodynamics of stereo isomeric drugs
 
Enzymes - A complete introduction and applications
Enzymes - A complete introduction and applicationsEnzymes - A complete introduction and applications
Enzymes - A complete introduction and applications
 
Gene Cards Assignment
Gene Cards AssignmentGene Cards Assignment
Gene Cards Assignment
 
D8 presentation
D8 presentationD8 presentation
D8 presentation
 
Des.term paper
Des.term paperDes.term paper
Des.term paper
 
Complexation & protein binding
Complexation & protein bindingComplexation & protein binding
Complexation & protein binding
 
medicinal chemistry .pptx
medicinal chemistry .pptxmedicinal chemistry .pptx
medicinal chemistry .pptx
 
Plasma Membrane (Structure and Functions)
 Plasma Membrane (Structure and Functions) Plasma Membrane (Structure and Functions)
Plasma Membrane (Structure and Functions)
 
Drug discovery 30
Drug discovery 30Drug discovery 30
Drug discovery 30
 
Stereochemistry
StereochemistryStereochemistry
Stereochemistry
 
Peiper 1
Peiper 1Peiper 1
Peiper 1
 
William Stockham Mchem Project
William Stockham Mchem ProjectWilliam Stockham Mchem Project
William Stockham Mchem Project
 
Structure activity relationship main
Structure activity relationship mainStructure activity relationship main
Structure activity relationship main
 
Drug discovery 30
Drug discovery 30Drug discovery 30
Drug discovery 30
 
Assignment on isomerism
Assignment on isomerismAssignment on isomerism
Assignment on isomerism
 
Hypotonic Isotonic And Hypertonic Solutions
Hypotonic Isotonic And Hypertonic SolutionsHypotonic Isotonic And Hypertonic Solutions
Hypotonic Isotonic And Hypertonic Solutions
 

Recently uploaded

GBSN- Microbiology (Lab 3) Gram Staining
GBSN- Microbiology (Lab 3) Gram StainingGBSN- Microbiology (Lab 3) Gram Staining
GBSN- Microbiology (Lab 3) Gram Staining
Areesha Ahmad
 
platelets_clotting_biogenesis.clot retractionpptx
platelets_clotting_biogenesis.clot retractionpptxplatelets_clotting_biogenesis.clot retractionpptx
platelets_clotting_biogenesis.clot retractionpptx
muralinath2
 
Lateral Ventricles.pdf very easy good diagrams comprehensive
Lateral Ventricles.pdf very easy good diagrams comprehensiveLateral Ventricles.pdf very easy good diagrams comprehensive
Lateral Ventricles.pdf very easy good diagrams comprehensive
silvermistyshot
 
Lab report on liquid viscosity of glycerin
Lab report on liquid viscosity of glycerinLab report on liquid viscosity of glycerin
Lab report on liquid viscosity of glycerin
ossaicprecious19
 
justice-and-fairness-ethics with example
justice-and-fairness-ethics with examplejustice-and-fairness-ethics with example
justice-and-fairness-ethics with example
azzyixes
 
Comparative structure of adrenal gland in vertebrates
Comparative structure of adrenal gland in vertebratesComparative structure of adrenal gland in vertebrates
Comparative structure of adrenal gland in vertebrates
sachin783648
 
Predicting property prices with machine learning algorithms.pdf
Predicting property prices with machine learning algorithms.pdfPredicting property prices with machine learning algorithms.pdf
Predicting property prices with machine learning algorithms.pdf
binhminhvu04
 
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Sérgio Sacani
 
platelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptxplatelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptx
muralinath2
 
NuGOweek 2024 Ghent - programme - final version
NuGOweek 2024 Ghent - programme - final versionNuGOweek 2024 Ghent - programme - final version
NuGOweek 2024 Ghent - programme - final version
pablovgd
 
ESR_factors_affect-clinic significance-Pathysiology.pptx
ESR_factors_affect-clinic significance-Pathysiology.pptxESR_factors_affect-clinic significance-Pathysiology.pptx
ESR_factors_affect-clinic significance-Pathysiology.pptx
muralinath2
 
Unveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdfUnveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdf
Erdal Coalmaker
 
GBSN - Biochemistry (Unit 5) Chemistry of Lipids
GBSN - Biochemistry (Unit 5) Chemistry of LipidsGBSN - Biochemistry (Unit 5) Chemistry of Lipids
GBSN - Biochemistry (Unit 5) Chemistry of Lipids
Areesha Ahmad
 
Viksit bharat till 2047 India@2047.pptx
Viksit bharat till 2047  India@2047.pptxViksit bharat till 2047  India@2047.pptx
Viksit bharat till 2047 India@2047.pptx
rakeshsharma20142015
 
Richard's aventures in two entangled wonderlands
Richard's aventures in two entangled wonderlandsRichard's aventures in two entangled wonderlands
Richard's aventures in two entangled wonderlands
Richard Gill
 
Hemostasis_importance& clinical significance.pptx
Hemostasis_importance& clinical significance.pptxHemostasis_importance& clinical significance.pptx
Hemostasis_importance& clinical significance.pptx
muralinath2
 
In silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptxIn silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptx
AlaminAfendy1
 
insect taxonomy importance systematics and classification
insect taxonomy importance systematics and classificationinsect taxonomy importance systematics and classification
insect taxonomy importance systematics and classification
anitaento25
 
Structures and textures of metamorphic rocks
Structures and textures of metamorphic rocksStructures and textures of metamorphic rocks
Structures and textures of metamorphic rocks
kumarmathi863
 
Nutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technologyNutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technology
Lokesh Patil
 

Recently uploaded (20)

GBSN- Microbiology (Lab 3) Gram Staining
GBSN- Microbiology (Lab 3) Gram StainingGBSN- Microbiology (Lab 3) Gram Staining
GBSN- Microbiology (Lab 3) Gram Staining
 
platelets_clotting_biogenesis.clot retractionpptx
platelets_clotting_biogenesis.clot retractionpptxplatelets_clotting_biogenesis.clot retractionpptx
platelets_clotting_biogenesis.clot retractionpptx
 
Lateral Ventricles.pdf very easy good diagrams comprehensive
Lateral Ventricles.pdf very easy good diagrams comprehensiveLateral Ventricles.pdf very easy good diagrams comprehensive
Lateral Ventricles.pdf very easy good diagrams comprehensive
 
Lab report on liquid viscosity of glycerin
Lab report on liquid viscosity of glycerinLab report on liquid viscosity of glycerin
Lab report on liquid viscosity of glycerin
 
justice-and-fairness-ethics with example
justice-and-fairness-ethics with examplejustice-and-fairness-ethics with example
justice-and-fairness-ethics with example
 
Comparative structure of adrenal gland in vertebrates
Comparative structure of adrenal gland in vertebratesComparative structure of adrenal gland in vertebrates
Comparative structure of adrenal gland in vertebrates
 
Predicting property prices with machine learning algorithms.pdf
Predicting property prices with machine learning algorithms.pdfPredicting property prices with machine learning algorithms.pdf
Predicting property prices with machine learning algorithms.pdf
 
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
 
platelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptxplatelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptx
 
NuGOweek 2024 Ghent - programme - final version
NuGOweek 2024 Ghent - programme - final versionNuGOweek 2024 Ghent - programme - final version
NuGOweek 2024 Ghent - programme - final version
 
ESR_factors_affect-clinic significance-Pathysiology.pptx
ESR_factors_affect-clinic significance-Pathysiology.pptxESR_factors_affect-clinic significance-Pathysiology.pptx
ESR_factors_affect-clinic significance-Pathysiology.pptx
 
Unveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdfUnveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdf
 
GBSN - Biochemistry (Unit 5) Chemistry of Lipids
GBSN - Biochemistry (Unit 5) Chemistry of LipidsGBSN - Biochemistry (Unit 5) Chemistry of Lipids
GBSN - Biochemistry (Unit 5) Chemistry of Lipids
 
Viksit bharat till 2047 India@2047.pptx
Viksit bharat till 2047  India@2047.pptxViksit bharat till 2047  India@2047.pptx
Viksit bharat till 2047 India@2047.pptx
 
Richard's aventures in two entangled wonderlands
Richard's aventures in two entangled wonderlandsRichard's aventures in two entangled wonderlands
Richard's aventures in two entangled wonderlands
 
Hemostasis_importance& clinical significance.pptx
Hemostasis_importance& clinical significance.pptxHemostasis_importance& clinical significance.pptx
Hemostasis_importance& clinical significance.pptx
 
In silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptxIn silico drugs analogue design: novobiocin analogues.pptx
In silico drugs analogue design: novobiocin analogues.pptx
 
insect taxonomy importance systematics and classification
insect taxonomy importance systematics and classificationinsect taxonomy importance systematics and classification
insect taxonomy importance systematics and classification
 
Structures and textures of metamorphic rocks
Structures and textures of metamorphic rocksStructures and textures of metamorphic rocks
Structures and textures of metamorphic rocks
 
Nutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technologyNutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technology
 

STEREOCHEMISTRY AND DRUG ACTION.pptx

  • 1. PRESENTED BY: ACHAL YAWALKAR M.PHARM I YEAR PHARMACEUTICAL CHEMISTRY GUIDED BY: Dr. B.R. PRASHANTHA KUMAR ASSOCIATE PROFESSOR DEPT OF PHARMACEUTICAL CHEMISTRY
  • 2. Elements 1. WHAT ARE ISOMERS ? 2. WHAT ARE STEREOISOMERS ? 3. WHAT IS CHIRALITY ? 4. WHAT DO YOU UNDERSTAND BY THE TERM ENATIOSELECTIVITY & HOW IS IT RELATED TO VARIOUS PHARMACOKINETIC PARAMETERS ?
  • 3. STEREOCHEMISTRY Stereochemistry is the branch of chemistry that involves “the study of the different spatial arrangements of atoms in molecules”.  Stereochemistry is the ‘chemistry of space’ , that is stereochemistry deals with the spatial arrangements of atoms and groups in a molecule.  Stereochemistry can trace its roots to the year 1842 when the French chemist Louis Pasteur made an observation that the salts of tartaric acid collected from a wine production vessel have the ability to rotate plane-polarized light, whereas the same salts from different sources did not have this ability.
  • 4. ISOMERS: Stereoisomers are molecules having the same molecular formula and the atomic arrangement, but differ in their spatial arrangement. Isomers are compounds that contain exactly the same number of atoms, i.e., they have exactly the same empirical formula, but differ from each other by the way in which the atoms are arranged. STEREOISOMERS: Constitutional isomers, also known as structural isomers, are specific types of isomers that share the same molecular formula but have different bonding atomic organization and bonding patterns. CONSTITUTIONAL ISOMERS:
  • 5. GEOMETRIC ISOMERS: Geometric isomers are two or more coordination compounds which contain the same number and types of atoms, and bonds (i.e., the connectivity between atoms is the same), but which have different spatial arrangements of the atoms.  There are 2 types of geometric isomers, ‘cis’ and ‘trans’. -cis isomers: when similar groups are present on the same side of the double bonds, then they are termed as cis. - trans isomers: when similar groups are present on the opposite sides of the double bonds then they are called trans isomers.  cis-diethylstilbestrol has only 7% of the estrogenic activity of trans- diethylstilbesterol.  Cisplatin have anticancer activity where ae trans platin is an inactive compound.
  • 6.  In chemistry, a molecule or ion is called chiral if it cannot be superposed on its mirror image by any combination of rotations, translations, and some conformational changes.  Chirality is the property of being non identical to ones mirror image. CHIRALITY:  Chiral center is defined as the atom bearing 4 different atoms or group of atoms.  Molecules that form nonsuperimposable mirror images, and thus exist as enantiomers, are said to be chiral molecules.  For a molecule to be chiral, it cannot contain a plane of symmetry. A plane of symmetry is a plane that bisects an object (a molecule, in this case) in such a way that the two halves are identical mirror images.
  • 7. ENATIOSELECTIVITY: The term enantioselectivity refers to the efficiency with which the reaction produces one enantiomer. ENANTIOMERS DIASTEREOMERS  Enantiomers are stereoisomers that are non-superimposable mirror images.  Have identical properties.  Similar shapes  Diastereomers are stereoisomers that are non superimposable and are not mirror images.  Have distinct physical properties.  Have different molecular shapes.
  • 8.
  • 9. ENANTIOMERS  Enantiomers consist of a pair of molecules that are mirror images of each other and are not superimposable.  When a molecule contains only one chiral centre , the two stereoisomers are known as enantiomers.  These may be referred to or labelled using the configurational descriptors as either:  R(rectus meaning right handed) or S(sinister meaning left handed),  D(dextrorotatory)or L (laevorotatory)  E-Entgegen (high priority groups on opposite side of double bond) or Z- Zusamen (high priority groups on same side of double bond)
  • 10. The most famous example of a chiral drug is Thalidomide. Thalidomide has a tragic history :  It was introduced in Germany in 1957 as a sedative and hypnotic and was marketed over the counter largely as a drug for treating morning sickness in pregnant women.  In the following few years, about 10,000 infants worldwide were born with phocomelia, or limb malformation. Only half of the infants survived, and some of those who did had other defects in addition to limb deficiencies.  Thalidomide exists in two mirror-image forms: it is a racemic mixture of (R)- and (S)-enantiomers. The (R)- enantiomer, shown in the figure, has sedative effects, whereas the (S)-isomer is teratogenic. Under biological conditions, the isomers interconvert, so separating the isomers before use is ineffective. The thalidomide disaster caused many countries to tighten drug approval regulations.
  • 11.  Vigabatrin, one of the most widely used antiepileptic drugs, is marketed and administered as a racemic mixture in which only S-enantiomer is therapeutically effective. R- Vigabatrin S-Vigabatrin  Tramadol is marketed as a racemic mixture of both R- and S- stereoisomers, because the two isomers complement each other's analgesic activities .  The (+)-isomer is predominantly active as an opiate with a higher affinity for the µ-opiate receptor (20 times higher affinity than the (-)- isomer).
  • 12. PHARMACOKINETIC PARAMETERS: 1.Absorption Passive intestinal absorption Carrier transporter stereoselectivity Oral bioavailability Local blood flow 2. Distribution Protein binding Tissue distribution Storage mechanism Tissue uptake transporter Efflux process 3.Metabolism First pass metabolism Phase 1 and Phase 2 metabolism 4. Elimination Glomerular Filtration Active secretion Passive & active reabsorption.
  • 13. The process of movement of drug from its site of administration to systemic circulation is called as absorption. Most important mechanism of drug absorption is passive diffusion through biological membranes, a process that is dependent upon the physicochemical properties of the molecule: i. Lipid solubility ii. pKa iii. Molecular size iv. Dissloution time v. Drug stability …..etc If a chiral drug is absorbed by a passive process then differences between enantiomers would not be expected. In contrast , diastereoisomers may show differences in absorption as a result of the differences in their solubility i.e Enantiomeric Do not show any differences in the absorption rate Diastereomeric May show differences in absorption as a result of the differences in their solubility.
  • 14. The aqueous solubility of ampicillin with 2R stereochemistry in the acylated side chain (corresponding to D- configuration) is greater than that of 2S epimer (L-configuration in side chain). Many of the b-lactam antibiotics are substrates for the gut dipeptide transport system and as such their absorption would be expected to be stereoselective.  The influence of the stereochemistry of the 7-acyl side chain on the absorption of the diastereoisomers of cefalexin has been investigated in the rat.  Both diastereoisomers are substrates for the carrier-mediated transport system with the L-epimer showing a higher affinity than, and acting as a competitive inhibitor for, D-cefalexin transport.  However, the L-epimer is also more susceptible to the intestinal wall peptidases and cannot be detected in serum, whereas the D- isomer is well absorbed. The drug is marketed as the single D- epimer
  • 15. i)There was 15% difference in bioavailability of the enantiomers of Atenolol. It was postulated that this was a result of an enantioselective active absorption. ii)Esomeprazole( Nexium) is more bioavailable than racemic omeprazole( Prilosec). iii)Greater bioavailability of (-)R-terbutaline compared to the less active (+)S- enantiomer is due to the result of stereoselectivity in first pass metabolism and due to (- ) enantiomer posses increasing membrane permeability in absorption.
  • 16. Difference in the absorption of enantiomers may also due to difference in their effect on local blood flow. (-) Bupivacaine has a longer duration of action than (+) Bupivacaine following intradermal injection. This difference in activity is due to vasoconstrictor effects of the (-) enantiomer reducing blood flow locally. The majority of the drugs undergo reversible binding to plasma proteins. • In case of chiral drugs, the drug enantiomer- protein complexes are diastereoisomeric and individual enantiomers would be expected to exhibit differences in binding affinity to the circulating proteins. • The differences in the binding affinity result in differences between enantiomers in free or unbound fraction that is able to distribute into the tissue.
  • 17. The two most important plasma proteins with respect to drug binding are human serum albumin (HSA) and alpha1-acid glycoprotein (AGP). a) Generally acidic drugs bind to HSA and basic drugs bind to AGP. b) Differences between enantiomers in the plasma protein binding may be relatively small and in some cases less than1%. Stereoselectivity in plasma protein binding also influences clearance for drugs, total clearance being proportional to fraction bound. Differences between enantiomers for plasma protein-binding sites may also result in pharmacokinetic complications. Most of the drug undergo reversible binding to plasma proteins. Types of plasma proteins are- -Human serum albumin -Weak acid to weak base drugs -Alpha-1 acid glycoproteins-Basic drugs -Lipoproteins- Basic lipophilic drugs -Alpha-1 globulin-Steroids -Alpha-2 globulin-Vitamins -Hemoglobin -Phenytoin, pentobarbital, etc
  • 18. Enantiomers display different magnitudes of stereoselectivity between various proteins found in plasma. 1. R- Propranolol binding to albumin is greater than S- propranolol and S enantiomer binding to alpha 1 glycoprotein is greater than R- albumin. 2. S- warfarin extensively binds to albumin than R – warfarin thus posses lower volume of distribution. 3.Levo cetrizin has lesser volume of distribution than its dextro isomer. R-Propranolol S- Warfarin Levo -cetrizin
  • 19. Enantioselectivity in binding may also vary between HSA and AGP. R- Propranolol Highly albumin bound Less potent Highly metabolized Low plasma concentration S- Propranolol Highly bound to AGP available as unbound 40 to 100 time more potent Less metabolized High plasma concentration
  • 20. (S)-oxazepam hemi succinate binds to HSA with an affinity 40 times than that of R-enantiomer. Enantioselective protein binding interaction was reported between warfarin and lorazepam acetate.  Where, R, S- warfarin allosterically increased the binding of S – Lorazepam acetate, but there was no effect of them on R enantiomer.  Similarly, S- lorazepam acetate increased the binding of R,S – Warfarin.
  • 21. Storage mechanisms: The S enantiomer of adreno receptor antagonists propranolol and atenolol undergo selective storage and secretion. The uptake of (-)- atenolol in to the storage granules has been reported to be 5 fold that of (+)- enantiomer. Stereoselective distribution may also occur as a result of interactions with: Tissue uptake transporter: E.g.: the BBB clearance of the R-enantiomer is four fold greater than that of either (S)-or racemic baclofen (Muscle relaxant).
  • 22. Stereoselectivity in metabolism may be associated with the binding of the substrate to the enzyme, and therefore associated with the chirality of the enzyme-binding site. Alternatively, selectivity may be associated with catalysis due to differential reactivity and/or orientation of potential target groups with respect to the enzyme catalytic site. The individual enantiomers of a racemic drug may be metabolized by different routes to yield different products and they are metabolized at different rates.
  • 23. The stereoselectivity of the reactions of drug metabolism may be associated with: • 1. Substrate stereoselectivity, i.e. the selective metabolism of one enantiomer compared to the other in either rate and/or route of metabolism • 2. Product stereoselectivity, i.e. the preferential formation of a particular stereoisomer rather than other possible stereoisomers • 3. Substrate product specificity, i.e. the selective metabolism of one enantiomer resulting in the preferential formation of one of a number of possible diastereoisomeric products. Prochiral to chiral transformations Chiral to chiral transformations Chiral to diastereo isomer transformations Chiral to achiral transformations Chiral inversions
  • 24. PROCHIRAL TO CHIRAL TRANSFORMATION: The molecule acquires chirality by metabolism, which may take place at either a prochiral centre or on an enantiotopic group bonded to it. Examples: The antiepileptic drug phenytoin has a prochiral center at carbon -5 of the hydantoin ring system and the two phenyl rings are enantiotopic as indicated by pro-S and pro-R. The major route of metabolism of phenytoin in both animals and humans involves aromatic oxidation which in human shows product stereoselectivity for formation of (S)-4- hydroxyphenytoin. CHIRAL TO CHIRAL TRANSFORMATION: In this type of transformations metabolism take place at a site in the molecule that does not alter the chirality of the metabolite relative to that of the drug. Example: Esmolol is an ultrashort acting relatively cardioselective B- adrenoreceptor antagonist, is used as a racemate but the pharmacological activity resides in the enantiomer of the S- configuration; the R-enantiomer is pharmacologically inactive. The ester functionality of esmolol is hydrolysed by the enzyme in blood esterases . The hydrolysis of S-esmolol is faster than that of the R-enantiomer in the animals whereas in human beings the hydrolysis of both enantiomers occur at similar rates.
  • 25. CHIRAL TO DIASTEREOISOMER TRANSFORMATION: This type of transformation involves the introduction of an additional stereogenic centre into a chiral molecule . Such centres may arise by a phase 1 or functionalization, metabolic reaction at a prochiral centre or by a phase 2, or conjugation, process by reaction with a chiral conjugating agent. Example: Reaction of a first type include reduction of the prochiral ketone group in warfarin to yield a pair of diastereoisomeric warfarin alcohols. In both rat and human, the reduction is substrate selective for (R)- warfarin and the predominantly formed isomer of the alcohol has S-configuration at the new centre. CHIRAL TO ACHIRAL TRANSFORMATIONS: In reactions of this type the biotransformation results in a loss of chirality, the reaction taking place at the stereogenic centre. Example: 1,4-dihydropyridine calcium channel blockers nitrendipine and nilvadipine .
  • 26. CHIRAL INVERSION: Chiral inversion is a relatively rare metabolic transformation and involves the conversion of a stereoisomer to its enantiomer with no other chemical change to the molecule. Example: The reaction was initially observed in 2-arylpropionic acid NSAID’s e.g. ibuprofen and since then it has been found to occur with the chemically related 2-aryloxypropionates, which are used as herbicides e.g. haloxyfop
  • 27. Renal excretion is the net result of glomerular filteration, active secretion and passive & active reabsorption. Since glomerular filteration is a passive process differences between enantiomers would not be expected. However, apparent stereoselectivity in renal clearance may arise as a consequence of stereoselectivity in protein binding. Active renal tubular secretion is thought to be responsible for the differential clearance of the enantiomers of number of basic drugs with stereoselectivities in the range of 1.1 to 3.0
  • 28. Eg : The renal clearance of quinidine is four times greater than its diastereoisomer quinine. For those agents that undergo active tubular secretions, the interactions between the enantiomers may occur in such a way that their excretions differs as single enantiomer or as a racemates. Ex- S- Ofloxacin administration with more of its R – enantiomer resulted in reduction of renal clearance of S- enantiomer. Mechanism followed was by competitive inhibitor of active transport system
  • 29. BIBLOGRAPHY: a) Smith and William’s introduction to principles of drug design, second edition, published by John wright, Pg.no.140-149 b) Burger’s Medicinal Chemistry And Drug Discovery, 6th edition, pg.no.782-787 c) Thomas L.L and David A Williams, Foye’s Principle of Medicinal Chemistry, 6th edition, Wolters Kluwer, Chapter 2 pg.24-36